Table 1.
Family | Sample | Phenotype | Diagnosis | Splice Classification | Transcript levels | Allele Imbalance |
---|---|---|---|---|---|---|
4a | f; m; myo | CM | RYR1 (GenBank: NM_001042723.1) c.2862G>A (p.Pro894Pro); RYR1 c.9859C>T (p. Arg3287>Cys) | exon extension | down 2× | no |
5 | f; m; myosingleton | CMD | GMPPB heterozygous (GenBank: NM_013334.3) c.94C>T (p.Pro32Ser); GMPPB heterozygous, 5′ UTR variant, g.349761246 G>A, new start codon | new start codon | down 4,1× | no |
6 | f; m; myosingleton | CMD | POMT2 (GenBank: NM_013382.5) c.1502A>C (p.Glu501Ala) homozygous | N/A | no | yes |
7a | f | CMD | LAMA2 (GenBank: NM_000426.3) c.9212–1G>A homozygous | exon extension | down 2,1× | no |
8 | msingleton | CM | TTN (GenBank: NM_001267550.2) c.74837_74840dupTTAG (p.Arg24947Ser∗2);TTN c.28114 +1G>A | exon extension | no | no |
9a | f; m; myo | DMD | DMD g.chrX: 32,366,860 A>C dbSNP: r.5326_5327ins51bp | novel exon | down 4,8× | X-linked disorder |
10a | m | CM | MTM1 (GenBanK: NM_000252.2) c.1262G>A (p.Arg421Gln) | N/A | no | X-linked disorder |
12 | f; m; myosingleton | CM | N/A | N/A | N/A | N/A |
13 | msingleton | CM | N/A | N/A | N/A | N/A |
14 | f; m; myo siblings | multiple pterygium syndrome | N/A | N/A | N/A | N/A |
15 | ftrio | MDC1A | LAMA2 (GenBank: NM_000426.3.) c.4860G>A; LAMA2 (GenBank: NM_000426.3) c.2584T>C (p.Cys862Arg) | exon skipping | down 2× | yes |
16 | f; myosingleton | restrictive cardiomyopathy | N/A | N/A | N/A | N/A |
17 | f; m; myosingleton | Pompe | GAA (NM_000152.5) c.−32–13T>G (intron 1); GAA c.1927G>A (p.Gly643Arg) | splice polypyrimidine tract variant | down 2× | yes |
18 | f; m; myosingleton | CMD | N/A | N/A | N/A | N/A |
21 | f; myosingleton | LGMD | N/A | N/A | N/A | N/A |
26 | f; m; myosingleton | DMD | UI for specific mutation | UI | down 7× | X-linked disorder |
27 | f; myosingleton | myopathy | N/A | N/A | N/A | N/A |
28 | f; m; myosingleton | CMD | N/A | N/A | N/A | N/A |
29 | fsingleton | myopathy | N/A | N/A | N/A | N/A |
30 | f; myosingleton | CMD | N/A | N/A | N/A | N/A |
31 | msingleton | arthrogryposis multiplex congenita | N/A | N/A | N/A | N/A |
32 | msingleton | CM | N/A | N/A | N/A | N/A |
33 | msingleton | distal myopathy | N/A | N/A | N/A | N/A |
34 | msingleton | DMD | DMD X: 33192302–33192451; UI for point mutation | novel exon | down 3,8× | X-linked disorder |
35 | msingleton | DMD | DMD (GenBank: NM_000109.3); c.93+1G>C exon 2 | exon extension | down 18,5x | X-linked disorder |
36 | msingleton | muscular dystrophy | N/A | N/A | N/A | N/A |
38 | msingleton | LGMD | DYSF (GenBank: NM_003494.3) c.4060_4062del (p.Ser1354del); UI for second mutation | novel exon | no | no |
39 | mproband & father | muscular dystrophy | N/A | N/A | N/A | N/A |
40 | f; m; myosiblings | recurrentrhabdomyolysis | N/A | N/A | N/A | N/A |
Abbreviations are as follows: Myo = myotubes; UI = under investigation; CM = congenital myopathy; CMD = congenital muscular dystrophy; LGMD = limb girdle muscle dystrophy; DMD = Duchenne muscular dystrophy; MDC1A = congenital muscular dystrophy 1A; m = male; and f = female. An extended version of the table is available in the Supplemental Data (Table S1).
Control samples.